Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microsaic Systems Appoints Colin Jump as New CEO

Published: Tuesday, November 06, 2012
Last Updated: Tuesday, November 06, 2012
Bookmark and Share
Company to drive the commercialization of its revolutionary chip-based technology.

With over 30 years of experience working in the analytical instrumentation sector, Colin has a proven track record helping companies to achieve significant growth and will bring a vast amount of commercial and operational acumen to the role.

Prior to joining Microsaic, Colin was responsible for developing and growing Shimadzu UK Ltd, a global manufacturer of scientific research instruments.

As UK Managing Director of Shimadzu UK Ltd for the past 11 years, Colin led the company using his extensive business experience and industry knowledge to implement comprehensive growth and marketing communication strategies, both of which will be invaluable in the development and growth of Microsaic Systems going forward.

Before managing Shimadzu UK Ltd, Colin was European Commercial Director at SGE Europe Ltd, which followed seven years in senior management and marketing positions at Mallinckrodt Baker in the UK and the Netherlands.

In addition, his prior roles in sales and marketing positions at Bayer Diagnostics, Boehringer Mannheim UK and Wellcome Diagnostics will undoubtedly be beneficial to Mircosaic Systems as it looks to establish its innovative chip-based scientific instruments within the analytical instrumentation market.

“Microsaic Systems is the first and only company to have commercialized MS (mass spectrometry) technology on a chip,” said Colin Jump.

“This places the company in an optimal position to deliver this gold standard technique for chemical analysis to a much wider range of users and applications.”

He continues, “I am excited to be joining Microsaic Systems at this crucial stage as it accelerates the commercialization of its revolutionary chip-based technology. With the ability to address major opportunities across multiple market areas I see huge potential for the technology and for the Company in the years ahead.”

“Our breakthrough product, the 3500 MiD, represents a step change in the ease of use and footprint of mass spectrometry. The instrument is smaller, lighter, consumes less energy, is easier to maintain and cheaper to run than conventional MS systems,” comments Eric Yeatman, Acting CEO of Microsaic Systems.

Yeatman continued, “The Board is very pleased to welcome Colin Jump to the company as our new CEO and I have no doubt his commercial and operational experience in the analytical instrumentation sector will help drive the business forward towards the further realization of our corporate goals.”

The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection.

Its low operating cost and small footprint make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach - until now.

Colin Jump will take up his role on 5th November 2012, at which point Eric Yeatman and Colin Nicholl will resume their former roles as Chairman and Deputy Chairman, respectively.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Microsaic Systems Signs Commercial Agreement
Second major agreement for novel miniaturized chip-based scientific instrument.
Thursday, April 11, 2013
Microsaic Systems Wins R&D 100 Award for the World’s Most Compact Mass Spectrometer
Microsaic’s 3500 MiD mass spectrometer has been chosen winner by an independent judging panel and the editors of R&D Magazine.
Friday, June 22, 2012
Microsaic Systems Appoint Sales and Marketing Manager
Microsaic Systems plc announces that Samantha Dunnage has joined to lead the Company’s marketing and direct sales.
Monday, August 08, 2011
Scientific News
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Coding and Computers Help Spot Methane, Explosives
Coded apertures improve and shrink mass spectrometers for field use.
Why Bearcats Smell Like Buttered Popcorn
Researchers pinpoint chemical compound that gives rare animal its popcorn-like scent.
UCSD Scientists Receive NIH Grant to Combat Antibiotic Resistance
Interdisciplinary program will use systems biology approaches to understand how antibiotics work in concert with patient’s immune system.
Virus Causing Tilapia Die-Offs Identified
Discovery of the virus causing Tilapia die-offs in Israel and Ecuador points the way to protecting a fish that feeds multitudes.
Novel Collagen Fingerprinting Identifies A Neanderthal
Study from the universities of Oxford and Manchester uses ZooMS technique to identify traces of an extinct human.
Hope for Combating Muscular Dystrophy
Decoding a sugar molecule and identifying a mechanism linking it to MS could help in the development of therapy for the disease.
Decoding Sugar Molecules Offers New Key For Combating Muscular Dystrophy
Japanese scientists find a rare sugar unit called ribitol 5-phosphate within the sugar molecules on the surface of muscle cells. Mutations in 3 genes linked to muscular dystrophy affect the creation of this sugar molecule.
A Vision for Precision Medicine
The University of Manchester and the University of Dundee partner to share disease screening data.
New Targets for Diabetes, Inflammation Discovered
The Scripps Research Institute and Salk Scientists discover 'outlier' enzymes that could offer new targets to treat diabetes and inflammation.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!